Small Lymphocytic Lymphoma
📧 Sign up to get email alerts when something new happens for Small Lymphocytic Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-06-09Clinical Trial Update: A Multicenter Phase 2 Study of Ibrutinib in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) With 17p Deletion [Phase 2]
Phase 2 multicenter study evaluating ibrutinib in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma with 17p…
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
Phase 2 trial of ofatumumab in patients with previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma has completed, …
-
CLINICAL_TRIALS trial_result · 2015-04-16Clinical Trial Update: Efficacy and Safety Study of PCI-32765 Combine With Ofatumumab in CLL [Phase 1, Phase 2]
Phase 1/2 trial results evaluate the efficacy and safety of combining ibrutinib (PCI-32765) with ofatumumab in B-cell chronic lymphocytic le…
-
CLINICAL_TRIALS trial_result · 2015-04-02Clinical Trial Update: Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 1]
Phase 1 trial evaluating lenalidomide with alvocidib in relapsed or refractory B-cell chronic lymphocytic leukemia and small lymphocytic lym…
-
CLINICAL_TRIALS trial_result · 2015-03-20Clinical Trial Update: Study of AMD3100 (Plerixafor) and Rituximab in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 1]
Phase 1 trial evaluating AMD3100 (Plerixafor) in combination with Rituximab in patients with chronic lymphocytic leukemia or small lymphocyt…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-03-06Clinical Trial Update: Lenalidomide With or Without Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Undergone Autologous or Syngeneic Stem Cell Transplant [Phase 2]
Phase 2 trial of lenalidomide with or without rituximab in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma after au…
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: Feasibility Study of a 60 Minute Rapid Infusion Rituximab Protocol in Patients With B-cell Malignancies [Phase 2]
A Phase 2 feasibility study evaluating a 60-minute rapid infusion rituximab protocol in patients with indolent or intermediate-grade B-cell …
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: A Study of Dinaciclib in Combination With Rituximab in Participants With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (P07974) [Phase 1]
This Phase 1 trial evaluated the combination of dinaciclib and rituximab in patients with chronic lymphocytic leukemia and small lymphocytic…
-
CLINICAL_TRIALS trial_result · 2015-01-27Clinical Trial Update: Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom Macroglobulinemia, or Mantle Cell Lymphoma [Phase 2]
Phase 2 clinical trial evaluating rituximab, cyclophosphamide, bortezomib, and dexamethasone in relapsed/refractory low-grade follicular lym…
-
CLINICAL_TRIALS trial_result · 2014-10-06Clinical Trial Update: Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]
This ClinicalTrials.gov update reports a terminated phase 1/2 trial evaluating fenretinide with rituximab for B-cell non-Hodgkin lymphomas; …
-
CLINICAL_TRIALS trial_result · 2014-09-04Clinical Trial Update: Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas [Phase 2]
Phase 2 trial assessing idelalisib for indolent B-cell non-Hodgkin lymphomas completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-08-13Clinical Trial Update: A Phase I Trial Using Cyclophosphamide, Rituximab and Revlimid (CR2) for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL) and Small Lymphocytic Lymphoma (SLL) [Phase 1]
This document reports the termination of a Phase I trial evaluating cyclophosphamide, rituximab, and lenalidomide (CR2) for relapsed/refract…
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Safety and Tolerability Study of PCI-32765 Combined With Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL) [Phase 1]
Phase 1 safety and tolerability study evaluating the BTK inhibitor PCI-32765 (ibrutinib) in combination with FCR or BR regimens in chronic l…
-
FDA approval · 2014-07-23FDA Approved: ZYDELIG — Original Application (Gilead Sciences, Inc.)
FDA approved ZYDELIG (idelalisib) from Gilead Sciences as a new molecular therapy for adults with relapsed or refractory follicular lymphoma…
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: Imexon for Relapsed Follicular and Aggressive Lymphomas [Phase 2]
Phase 2 clinical trial results for imexon in relapsed follicular lymphoma and various aggressive B-cell lymphomas have been completed with r…
-
CLINICAL_TRIALS trial_result · 2014-06-20Clinical Trial Update: Pentostatin, Alemtuzumab, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
Phase 2 trial evaluating a combination of pentostatin, alemtuzumab, and rituximab in relapsed or refractory chronic lymphocytic leukemia or …
-
CLINICAL_TRIALS research · 2014-06-05Clinical Trial Update: Observational Study of Low Dose FCR in Elderly/Comorbid CLL/SLL: The Q-lite Project
Observational study (the Q-lite Project) evaluating low-dose fludarabine-cyclophosphamide-rituximab (FCR) in elderly or comorbid patients wi…
-
CLINICAL_TRIALS other · 2014-05-23Clinical Trial Update: Study of Motexafin Gadolinium (MGd) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
A phase 2 trial of Motexafin Gadolinium in chronic lymphocytic leukemia or small lymphocytic lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Pentostatin, Cyclophosphamide, and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
Phase 2 trial assessing pentostatin, cyclophosphamide, and rituximab with or without bevacizumab in patients with chronic lymphocytic leukem…
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Safety and Tolerability of XmAb®5574 in Chronic Lymphocytic Leukemia [Phase 1]
A Phase 1 study evaluating safety and tolerability of XmAb5574 in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma …
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: Safety of PCI-32765 in Chronic Lymphocytic Leukemia [Phase 1, Phase 2]
Clinical trial update reporting safety data for the BTK inhibitor ibrutinib (PCI-32765) in patients with chronic lymphocytic leukemia and sm…
-
FDA approval · 2014-03-27FDA Approved: TREANDA — Supplemental Application (Cephalon, LLC)
FDA approved a supplemental application for TREANDA (bendamustine hydrochloride) submitted by Cephalon, LLC.
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Phase 2]
A Phase 2 clinical trial evaluating CCI-779 (temsirolimus) in patients with recurrent or refractory B-cell non-Hodgkin lymphoma or chronic l…
-
CLINICAL_TRIALS trial_result · 2014-02-10Clinical Trial Update: Sunitinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
Phase 2 trial evaluating sunitinib in relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma has completed with …
-
CLINICAL_TRIALS trial_result · 2014-01-13Clinical Trial Update: Lenalidomide in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 2]
This Phase 2 clinical trial update evaluates lenalidomide in previously treated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma.…